Objectives: The objectives of this study were to compare preoperative and postoperative tumor grade to determine if surgical staging decisions for endometrial cancer based on preoperative biopsy are feasible and whether obesity affects the agreement. Methods: A retrospective cohort study of women with endometrial cancer between January 2010 and December 2011 was performed. Demographics, stage of final pathology, biopsy method, preoperative and postoperative tissue grade, and histology were abstracted and stratified by patient body mass index (obese Q30 kg/m 2 and nonobese G30 kg/m 2 ). Patients with incomplete records or uterine sarcoma were excluded. The agreement between preoperative and postoperative tumor grade for all patients and in obese and nonobese patients was determined using weighted J statistics. Results: Four hindered forty-five patients were included: 161 nonobese patients and 284 obese patients. The proportion of preoperative sampling via office biopsy and dilation and curettage was similar in each cohort. Overall, the agreement between preoperative and postoperative pathology was only fair (weighted J = 0.21). Stratified by body mass index, the agreement between preoperative and postoperative grade remains fair in obese and slight in nonobese patients (weighted J = 0.21 and 0.19, respectively). Substantial increases in tumor grade from preoperative to postoperative pathologic specimens occurred in both cohorts. Conclusions: Obesity does not appear to significantly alter the correlation between preoperative biopsy and final tumor grade. With only fair correlation between preoperative and postoperative pathologic evaluation, utilization of preoperative biopsy pathology results as a triage tool for surgical staging should be avoided. However, the discordance between preoperative and postoperative pathology in favor of a higher grade on final pathology in both groups may cause some surgeons to favor staging.
E ndometrial cancer (EMCA) remains the most common gynecologic cancer in the United States with an estimated 54,870 new cases being diagnosed in 2015 and a continued rise in incidence of the last decade. 1 Obesity is a well-recognized risk factor for type I EMCA due to excess unopposed estrogen production in overabundant adipose tissue. 2Y8 Recent data demonstrate 36% of women in the United States are obese with a body mass index (BMI) greater than 30 kg/m 2 , and 8% are morbidly obese with a BMI greater than 40 kg/m 2 . 9 In the diagnostic workup for abnormal uterine bleeding (AUB), transvaginal ultrasound (TVUS) is often used to evaluate the endometrial cavity. Research has shown that the most cost-effective strategy for diagnosing EMCA in women with AUB is to first obtain a TVUS then an endometrial biopsy when indicated. 10, 11 While an endometrial stripe thickness of 4 mm or less is reassuring for a benign process, the quality of the images rendered by ultrasound can vary according to patient comorbidities such as diabetes and obesity. 10 Van Doorn and colleagues 10 noted that obesity decreased the accuracy of endometrial stripe thickness measurement on TVUS such that the authors called into question the clinical utility of ultrasound in obese women when evaluating postmenopausal bleeding. Most patients with a diagnosis of EMCA have undergone endometrial sampling either via in-office biopsy with an endometrial Pipelle or dilation and curettage (D&C). While studies have demonstrated that both methods of endometrial sampling have favorable specificities for diagnosing EMCA and that this is more accurate than a TVUS in premenopausal versus postmenopausal women, it is unknown if there is any effect of obesity on the correlation between tumor grade on a preoperative biopsy specimen and final surgical pathology.
12Y16
While total hysterectomy with bilateral salpingooophorectomy is the preferred therapy for EMCA management in women who have completed childbearing and who do not have other comorbidities that would preclude surgical management, the role of surgical staging continues to be debated. 17 Gynecologic oncologists utilize several approaches in order to identify EMCA patients to undergo surgical staging. Decisions for surgical staging can be based on preoperative biopsy results, intraoperative assessment of tumor size and depth of invasion, and intraoperative frozen section; however, the preoperative decision to proceed with either full surgical staging or sentinel node biopsy is also utilized in contemporary EMCA management.
18Y24 Several studies have demonstrated comprehensive surgical staging in nonobese versus obese patients to have comparable safety when evaluating intraoperative and postoperative complications, intensive care unit stays, and length of hospital stay; however, increasing BMI leads to longer operative times, higher conversion from laparoscopic to open procedures, and decreased ability to complete lymph node dissection. 25Y28 Because obesity has been shown to negatively affect the accuracy of the diagnostic workup of EMCA using TVUS, our goal was to determine whether histologic evaluation is affected also by obesity. 10 More specifically, is the level of agreement between preoperative and postoperative tumor grade in EMCA patients impacted by obesity? We also sought to establish if the preoperative and final surgical pathology correlate in such a way that preoperative tumor grade can be reliably used when deciding whether to proceed with surgical staging.
METHODS
Following institutional review board approval, a retrospective cohort study of women undergoing surgical management for diagnosed complex atypical hyperplasia (CAH) or EMCA between January 2010 and December 2011 was performed. Medical records were abstracted to obtain age at diagnosis, race, BMI, preoperative endometrial sampling method, histology, tumor grade, surgical approach, final pathology, and adjuvant chemotherapy or radiation therapy. Final pathologic evaluation included histologic cell type, depth of myometrial invasion, lymphovascular space invasion, and nodal disease. Patients were excluded from analysis if they had incomplete medical records or if preoperative pathology revealed uterine sarcoma or carcinosarcoma.
Preoperative biopsy pathology was not reviewed for all patients as a large number of these evaluations were done at outside facilities, and slides were not available for review. Pathologists specializing in gynecologic oncology pathology reviewed all final surgical pathology specimens, and the histologic grade was determined by the International Federation of Gynecology and Obstetrics criteria. Intraoperative frozen section was not performed out of concern for reliable results at our institution. Gynecologic oncologists at a large academic center performed all surgical procedures removing the tissues evaluated on final pathology.
A comparison of preoperative and postoperative tumor grade was made in all patients. Patients were then stratified by BMI into an obese group with a BMI 30 kg/m 2 or greater and nonobese group with a BMI less than 30 kg/m 2 . Weighted J coefficients were used to compare preoperative and postoperative tumor grades in both groups. Differences in baseline characteristics between the obese and nonobese groups were compared using W 2 and Fisher exact tests. W 2 Tests were used to compare the preoperative and final tumor grade and histology between the obese and nonobese groups. SAS version 9.2 (SAS Institute, Cary, NC) was utilized to perform all analyses.
RESULTS
Five hundred twenty-six women met study inclusion criteria, of which 81 patients were excluded: 63 had incomplete records, and on preoperative biopsy, 18 had either uterine sarcoma or carcinosarcoma. Of the total 445 women included in this study, 161 were identified as nonobese with a BMI of less than 30 kg/m 2 , and 284 were obese with a BMI of 30 kg/m 2 or greater. Patient demographics are listed in Table 1 . Notably, the mean BMI was 25.5 (SD, 3.5) kg/m 2 in the nonobese group. Ninety patients (55.9%) underwent a preoperative endometrial biopsy, Sixty-nine patients (42.9%) had a D&C, whereas 2 patients (1.2%) underwent sampling that was not explicitly stated. In the obese cohort, the mean BMI was 39.6 (SD, 7.8) kg/m 2 . One hundred forty-five patients (51.1%) had an endometrial biopsy, 137 patients (48.2%) had a D&C, and it is unknown how 2 of the patients (0.7%) were sampled. The obese and nonobese groups were similar in baseline characteristics with a few exceptions: in the nonobese group, the patients were older, and in the obese group, there were more black women (Table 1) .
The preoperative and final tumor grade and histology for both cohorts are displayed in Table 2 . Based on preoperative biopsy, the majority of patients had cancer (n = 403, 90.6%). The most common histology was endometrial adenocarcinoma, not otherwise specified (n = 320, 71.9%). No statistically significant differences were noted between the cohorts in terms of preoperative tumor grade, although both CAH (n = 30 [ On final pathology, endometrioid adenocarcinoma was the most common histology (n = 372 [83.6%]). The differences in histology between the 2 cohorts were not statistically significant (P = 0.457). Grade 1 disease was more common in the obese cohort (n = 47 [16.5%]) than in the nonobese cohort (n = 19 [11.8%] ). Interestingly, the majority of patients in both the obese (n = 142 [50.0%]) and nonobese groups (n = 100 [62.1%]) had grade 3 disease, which was a substantial increase in the proportion of patients with grade 3 tumors as compared with preoperative biopsy results. The difference for tumor grade between the 2 groups was not statistically significant (P = 0.086).
The agreement between preoperative and postoperative tumor grade among all patients included in this study was fair as the weighted J was 0.21. When stratified by BMI, the agreement between preoperative and postoperative grade remains only fair in obese and slight in nonobese patients with weighted J's of 0.21 and 0.19 respectively, P = 0.77 (Table 3) . When the discordance between preoperative and postoperative histology is broken down further, we found that, overall, substantial increases in tumor grade from preoperative to postoperative pathologic specimens occurred. In the nonobese cohort, grade 1 disease was upgraded to grade 2 disease in 10 patients and grade 3 disease in 8 patients. In addition, grade 2 disease was upgraded to grade 3 disease in 34 patients, and CAH was upgraded to grade 2 disease in 6 patients and grade 3 in 3 patients. Some histology was downgraded as 10 patients with grade 3 disease were found to have grade 2 disease on final pathology. There was even more upgrading in the obese cohort as CAH was upgraded to grade 1 disease in 15 patients, grade 2 disease in 12 patients, and grade 3 disease in 3 patients. In patients with grade 1 disease initially, final pathology found grade 2 disease in 15 patients and grade 3 disease in 4 patients. Fifty-five patients with grade 2 disease were upgraded to grade 3 disease. Final pathologic evaluation downgraded 11 patients from grade 2 to grade 1 disease and 13 patients from grade 3 to grade 2 disease. The differences between the number of upgrades for each pathologic grade within the nonobese and obese groups were statistically significant (P = 0.0003 and P = G0.0001, respectively) ( Table 4) .
DISCUSSION
Type I EMCAs are directly linked to obesity due to excess estrogen exogenously produced in adipose tissue, which then stimulates proliferation of the endometrium.
6Y8
Newer studies have found relationships between not only obesity but also insulin resistance and increased androgen levels in the pathogenesis of EMCA due to inflammatory mediators, adiponectin, leptin, plasminogen activator inhibitor 1, and insulinlike growth factor 1.
29Y31 While data support equivalent specificities between endometrial sampling via either in-office biopsy or D&C, no studies have investigated whether obesity affects the correlation between preoperative biopsy and final pathologic tumor grade.
12Y16 Because obesity has been shown to affect some aspects of preoperative diagnostic workup, preoperative information such as preoperative biopsy, which reliably predicts final tumor grade, could be invaluable to surgeons trying to decrease the morbidity of an operation that has been shown to be higher when full staging is performed on obese women.
10,24Y27 In our study, we found that changes in tumor grade were more pronounced (and more frequent) in obese women than in a similar group of nonobese women.
Full surgical staging for EMCA includes a total hysterectomy and bilateral salpingo-oophorectomy with a pelvic and para-aortic lymphadenectomy despite the fact that studies have shown there is a low risk of nodal metastases in patients with early-stage disease. 32, 33 Two randomized trials found no difference in overall survival or progression-free survival in patients who underwent surgical staging in clinically early-stage EMCA with or without lymphadenectomy supporting the potential limitation of staging as a part of initial surgical management.
34Y36
Pelvic and para-aortic lymph node dissections can also lead to significant morbidity including lower-extremity lymphedema, lymphocele formation, neurovascular damage, and increased risk of thrombotic events.
37Y41
Surgeons rely on many different approaches including preoperative biopsy data, intraoperative frozen pathologic section, depth of myometrial invasion, size of the tumor, and also preoperative tumor grade to help decide which patients are at risk of nodal metastases and therefore need lymphadenectomy. Despite studies validating the low risk of nodal metastases in early-stage EMCA patients using these different triage techniques and considering the potential added morbidity following pelvic and para-aortic lymph node dissection, there is no complete consensus within the gynecologic oncology community as to the best way to identify patients who need operative lymph node evaluation.
18Y24,37Y41
Definitive decisions based on retrospective evaluations warrant caution when attempting to apply them to clinical practice. Nonetheless, our series is a large series of EMCA patients treated in a similar fashion during a 2-year period at a 42, 43 These discrepancies may be due to inadequate tumor volume on Pipelle biopsies, incorrect reporting of initial pathology, dedifferentiation of tumors as they invade the myometrium, procedural difficulties encountered in the obese patient, and/or inadequate immunohistochemistry. Moreover, our findings may have implications at smaller-volume institutions without dedicated gynecologic pathology support. We believe this lack or formal review of outside hospital preoperative biopsy pathology more accurately represents what occurs at many hospitals on a day-to-day basis where formal review of all pathologic specimens by gynecologic pathologists is not always possible.
We acknowledge there are slightly older women in the nonobese group and more African American women in the obese group. There is, however, a similar number of women with a given histologic subtype and distribution in histologic grade of disease when comparing preoperative and postoperative histology. This suggests age and race did not affect the incidence of high-grade tumor types in this study.
In our series of nearly 450 women, there was only fair correlation between preoperative and postoperative tumor grade that was not affected by obesity. Because we noted only fair correlation between preoperative and final tumor grade, utilization of preoperative biopsy results as a triage tool to determine surgical staging decisions should be avoided. Although there were a small number of discordances between preoperative and postoperative pathologic tumor grading, the majority of these resulted in an upgrade. The most common upgrade was from grade 2 to grade 3 disease in both the nonobese and obese groups with 34 and 55 upgrades, respectively. These discordances, more pronounced in the obese group, may ultimately result in some surgeons favoring surgical staging. In conclusion, while it is necessary to continue endometrial sampling for all patients with AUB concerning for underlying EMCA, those results alone should not be used to reach decisions on whether to perform or omit surgical staging. More studies are needed to further assess when it is prudent to perform surgical staging in early-stage EMCA patients.
Research Highlights
& Body mass index does not appear to affect the correlation between preoperative biopsy and postoperative final tumor grade. & There is only fair agreement between preoperative and postoperative tumor grade among all women with EMCA. & Tumor grade alone should not be used to determine which patients need surgical staging.
